University of Glasgow, Glasgow, UK.
Department of Cardiology, Queen Elizabeth University Hospital, Glasgow, UK.
Heart. 2024 Jun 17;110(13):908-915. doi: 10.1136/heartjnl-2023-323666.
Guidelines for the management of cardiovascular disease (CVD) recommend preconception risk stratification and counselling in all women of childbearing age. We assessed the provision of preconception counselling (PCC) among women of reproductive age attending general cardiology outpatient clinics over a 12-month period in two large health boards in Scotland.
Electronic health records were reviewed and data on patient demographics, cardiac diagnoses, medication use and the content of documented discussions regarding PCC were recorded. Women were classified according to the modified WHO (mWHO) risk stratification system. Among 1650 women with a cardiac diagnosis included (1 January 2016-31 December 2016), the mean age was 32.7±8.6 years, and 1574 (95.4%) attended a consultant-led clinic. A quarter (402, 24.4%) were prescribed at least one potentially fetotoxic cardiovascular medication. PCC was documented in 10.3% of women who were not pregnant or were unable to conceive at the time of review (159/1548). The distribution of mWHO classification, and proportion of patients within each mWHO category who received any form of PCC, was 15.0% and 6.0% in mWHO class I, 20.2% and 8.7% in mWHO class II, 22.6% and 10.6% in mWHO class II-III, 9.5% and 15.7% in mWHO class III and 3.9% and 19.7% in mWHO class IV.
PCC is documented infrequently in women of reproductive age with CVD in the general outpatient setting. Education relating to the risks of cardiac disease in pregnancy for clinicians and patients, and tools to support healthcare providers in delivering PCC, is important.
心血管疾病 (CVD) 管理指南建议在所有育龄妇女中进行孕前风险分层和咨询。我们评估了在苏格兰两个大型卫生委员会的普通心血管门诊就诊的育龄妇女在 12 个月期间接受孕前咨询 (PCC) 的情况。
电子健康记录进行了审查,并记录了患者人口统计学、心脏诊断、药物使用以及记录的关于 PCC 的讨论内容。女性根据改良的世界卫生组织 (mWHO) 风险分层系统进行分类。在纳入的 1650 名有心脏诊断的女性中(2016 年 1 月 1 日至 2016 年 12 月 31 日),平均年龄为 32.7±8.6 岁,其中 1574 名(95.4%)就诊于顾问主导的诊所。四分之一(402 名,24.4%)服用了至少一种潜在的致胎儿毒性心血管药物。在审查时未怀孕或无法怀孕的 1548 名女性中,有 10.3%记录了 PCC(159/1548)。mWHO 分类的分布以及每个 mWHO 类别的患者中接受任何形式的 PCC 的比例为 I 类 15.0%和 6.0%,II 类 20.2%和 8.7%,II-III 类 22.6%和 10.6%,III 类 9.5%和 15.7%,IV 类 3.9%和 19.7%。
在普通门诊环境中,记录育龄妇女 CVD 的 PCC 很少。向临床医生和患者提供与妊娠期间心脏疾病风险相关的教育,以及支持医疗保健提供者提供 PCC 的工具,非常重要。